Objective To review international policies to control expenditure on pharmaceuticals by
influencing the behaviour of patients and providers and regulating the pharmaceutical …

Abstract France, Germany, Sweden, and the United Kingdom each use different types of
policies for controlling prescription drug spending. Until recent years, these policies have …

Background The proportion of total healthcare expenditures spent on drugs has continued to
grow in countries of all income categories. Policy‐makers are under pressure to control …

Health costs, including the cost of pharmaceuticals, have been rising throughout the world
for 35 years. Governments are determined to reduce public expenditure on health; …

In the last 20 years, expenditures on pharmaceuticals—as well as total health expenditures—
have grown faster than the gross national product in all European countries. The aim of this …

Aim. To review pharmaceutical price regulation methods in countries of the European Union
(EU), in terms of the anticipated impact of regulation on pharmaceutical expenditures and …

Background: While the prices of pharmaceuticals are relatively low in Greece, expenditure
on them is growing more rapidly than almost anywhere else in the European Union …

European policy makers have increasingly moved from primarily focusing on supply-side
regulation of pharmaceutical costs to offering incentives for providers' prescribing behavior …

Background Pharmaceuticals can be important for people's health. At the same time drugs
are major components of health care costs. Pharmaceutical pricing and purchasing policies …

What can be learned from international experience of efforts to control spending and to
improve efficiency and access in pharmaceutical markets? Policymakers tend to reinvent …